Efficacy and safety of definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma

被引：0
|
作者：
Habu, Takumi
Bando, Hideaki
Kumanishi, Ryosuke
Ogata, Takatsugu
Fujisawa, Takeshi
Kumagai, Shogo
Fujiwara, Hisashi
Mishima, Saori
Kotani, Daisuke
Nakamura, Masaki
Hojo, Hidehiro
Yoda, Yusuke
Koyama, Shohei
Nishikawa, Hiroyoshi
Yano, Tomonori
Fujita, Takeo
Kadowaki, Shigenori
Muro, Kei
Kinoshita, Takahiro
Kojima, Takashi
机构：
[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[4] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr, Div Canc Immunol, Res Inst, Exploratory Oncol Res & Clin Trial Ctr EPOC, Kashiwa, Chiba, Japan
[6] Natl Canc Ctr Hosp East, Dept Radiat Oncol, Kashiwa, Chiba, Japan
[7] Natl Canc Ctr, Kashiwa, Chiba, Japan
[8] Natl Canc Ctr Hosp East, Dept Gastroenterol & Endoscopy, Kashiwa, Chiba, Japan
[9] Natl Canc Ctr Hosp East, Dept Gastrointestinal Med Oncol, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.252
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
252
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Atezolizumab following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
    Ooki, Akira
    Chin, Keisho
    Bando, Hideaki
    Kumagai, Shogo
    Kotani, Daisuke
    Mishima, Saori
    Habu, Takumi
    Tsushima, Takahiro
    Hara, Hiroki
    Kadowaki, Shigenori
    Kato, Ken
    Kensei, Yamaguchi
    Kageyama, Shun-Ichiro
    Hojo, Hidehiro
    Nakamura, Masaki
    Tachibana, Hidenobu
    Wakabayashi, Masashi
    Fukui, Makoto
    Fuse, Nozomu
    Nishikawa, Hiroyoshi
    Kojima, Takashi
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1381 - S1381
  • [2] Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
    Takumi Habu
    Ryosuke Kumanishi
    Takatsugu Ogata
    Takeshi Fujisawa
    Saori Mishima
    Daisuke Kotani
    Shigenori Kadowaki
    Masaki Nakamura
    Hidehiro Hojo
    Hisashi Fujiwara
    Shogo Kumagai
    Shohei Koyama
    Takeo Fujita
    Takahiro Kinoshita
    Hiroyoshi Nishikawa
    Tomonori Yano
    Masahiro Tajika
    Kei Muro
    Shuichi Mitsunaga
    Takashi Kojima
    Hideaki Bando
    [J]. Esophagus, 2023, 20 : 533 - 540
  • [3] Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
    Habu, Takumi
    Kumanishi, Ryosuke
    Ogata, Takatsugu
    Fujisawa, Takeshi
    Mishima, Saori
    Kotani, Daisuke
    Kadowaki, Shigenori
    Nakamura, Masaki
    Hojo, Hidehiro
    Fujiwara, Hisashi
    Kumagai, Shogo
    Koyama, Shohei
    Fujita, Takeo
    Kinoshita, Takahiro
    Nishikawa, Hiroyoshi
    Yano, Tomonori
    Tajika, Masahiro
    Muro, Kei
    Mitsunaga, Shuichi
    Kojima, Takashi
    Bando, Hideaki
    [J]. ESOPHAGUS, 2023, 20 (03) : 533 - 540
  • [4] The efficacy and safety of toripalimab combined with definitive chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma.
    Xi, Mian
    Zhu, Yujia
    Li, Qiao-Qiao
    Zhao, Lei
    Yang, Yadi
    Hu, Yonghong
    Liu, Mengzhong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
    Ochi, Masanori
    Murakami, Yuji
    Nishibuchi, Ikuno
    Kubo, Katsumaro
    Imano, Nobuki
    Takeuchi, Yuki
    Kimura, Tomoki
    Hamai, Yoichi
    Emi, Manabu
    Okada, Morihito
    Nagata, Yasushi
    [J]. JOURNAL OF RADIATION RESEARCH, 2021, 62 (01) : 142 - 148
  • [6] Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
    Yao, Bin
    Tan, Bingxu
    Wang, Cong
    Song, Qingxu
    Wang, Jianbo
    Guan, Shanghai
    Jia, Yibin
    Ma, Yanan
    Huang, Xiaochen
    Sun, Yi
    Cheng, Yufeng
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (07) : 2367 - 2372
  • [7] Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
    Bin Yao
    Bingxu Tan
    Cong Wang
    Qingxu Song
    Jianbo Wang
    Shanghai Guan
    Yibin Jia
    Yanan Ma
    Xiaochen Huang
    Yi Sun
    Yufeng Cheng
    [J]. Annals of Surgical Oncology, 2016, 23 : 2367 - 2372
  • [8] Serum squamous cell carcinoma antigen is a predictive factor of outcomes in patients with locally advanced unresectable esophageal squamous cell carcinoma treated by definitive chemoradiotherapy
    Suzuki, Takeshi
    Okamura, Akihiko
    Watanabe, Masayuki
    Asari, Takao
    Nakayama, Izuma
    Ogura, Mariko
    Ooki, Akira
    Takahari, Daisuke
    Yamaguchi, Kensei
    Chin, Keisho
    [J]. JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [9] Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Park, Sehhoon
    Oh, Dongryul
    Choi, Yoon-La
    Chi, Sang Ah
    Kim, Kyunga
    Ahn, Myung-Ju
    Sun, Jong-Mu
    [J]. CANCER, 2022, 128 (11) : 2148 - 2158
  • [10] Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
    Chih-Yi Chen
    Chia-Chin Li
    Chun-Ru Chien
    [J]. World Journal of Surgical Oncology, 16
12345